Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies to design clinical studies to identify predictive biomarkers in cancer research.
Perez-Gracia JL, Sanmamed MF, Bosch A, Patiño-Garcia A, Schalper KA, Segura V, Bellmunt J, Tabernero J, Sweeney CJ, Choueiri TK, Martín M, Fusco JP, Rodriguez-Ruiz ME, Calvo A, Prior C, Paz-Ares L, Pio R, Gonzalez-Billalabeitia E, Gonzalez Hernandez A, Páez D, Piulats JM, Gurpide A, Andueza M, de Velasco G, Pazo R, Grande E, Nicolas P, Abad-Santos F, Garcia-Donas J, Castellano D, Pajares MJ, Suarez C, Colomer R, Montuenga LM, Melero I. Perez-Gracia JL, et al. Cancer Treat Rev. 2017 Feb;53:79-97. doi: 10.1016/j.ctrv.2016.12.005. Epub 2016 Dec 30. Cancer Treat Rev. 2017. PMID: 28088073 Free article. Review.
High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma: a Phase II multicentric trial.
Pérez-Gracia JL, Colomer R, Esteban E, Barceló R, Benavides M, Puertas J, Arcediano A, Tornamira MV, Valentín V, Muñoz A, Cortés-Funes H, Hornedo J. Pérez-Gracia JL, et al. Cancer. 2001 Nov 15;92(10):2508-16. doi: 10.1002/1097-0142(20011115)92:10<2508::aid-cncr1601>3.0.co;2-#. Cancer. 2001. PMID: 11745183 Clinical Trial.
Assessment of the value of confirming responses in clinical trials in oncology.
Perez-Gracia JL, Muñoz M, Williams G, Wu J, Carrasco E, Garcia-Ribas I, Peiro A, Lopez-Picazo JM, Gurpide A, Chopitea A, Martín-Algarra S, García-Foncillas J, Blatter J. Perez-Gracia JL, et al. Eur J Cancer. 2005 Jul;41(11):1528-32. doi: 10.1016/j.ejca.2005.01.023. Eur J Cancer. 2005. PMID: 16026690
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma.
Arina A, Murillo O, Hervás-Stubbs S, Azpilikueta A, Dubrot J, Tirapu I, Huarte E, Alfaro C, Pérez-Gracia JL, González-Aseguinolaza G, Sarobe P, Lasarte JJ, Jamieson A, Prieto J, Raulet DH, Melero I. Arina A, et al. Int J Cancer. 2007 Sep 15;121(6):1282-95. doi: 10.1002/ijc.22795. Int J Cancer. 2007. PMID: 17520674 Free article.
[Small-cell lung cancer].
Pérez-Gracia JL, López-Picazo JM, Martín-Algarra S, Viteri S, García-Foncillas J, Gúrpide A. Pérez-Gracia JL, et al. Rev Med Univ Navarra. 2007 Apr-Jun;51(2):7-13. Rev Med Univ Navarra. 2007. PMID: 17886708 Review. Spanish.
[New treatments for renal carcinoma].
Pérez-Gracia JL, López-Picazo JM, Olier C, Alfaro C, García-Foncillas J, Melero I, Gúrpide A. Pérez-Gracia JL, et al. An Sist Sanit Navar. 2007 Sep-Dec;30(3):393-403. doi: 10.4321/s1137-66272007000500008. An Sist Sanit Navar. 2007. PMID: 18227896 Free article. Review. Spanish.
169 results